BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8822945)

  • 21. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia.
    Jeffs AR; Benjes SM; Smith TL; Sowerby SJ; Morris CM
    Hum Mol Genet; 1998 May; 7(5):767-76. PubMed ID: 9536079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
    Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
    Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consistent involvement of the 3' half part of the first BCR intron in adult Philadelphia-positive leukaemia without M-bcr rearrangement.
    Nakamura Y; Hirosawa S; Aoki N
    Br J Haematol; 1993 Jan; 83(1):53-7. PubMed ID: 8435337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible evidence for acquired genetic activity at both chromosomal breakpoints of the Philadelphia translocation in chronic myeloid leukemia.
    Yamada T; Secker-Walker LM
    Leukemia; 1990 May; 4(5):341-4. PubMed ID: 2388479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.
    Chissoe SL; Bodenteich A; Wang YF; Wang YP; Burian D; Clifton SW; Crabtree J; Freeman A; Iyer K; Jian L
    Genomics; 1995 May; 27(1):67-82. PubMed ID: 7665185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
    Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
    Wiedemann LM; Karhi KK; Shivji MK; Rayter SI; Pegram SM; Dowden G; Bevan D; Will A; Galton DA; Chan LC
    Blood; 1988 Feb; 71(2):349-55. PubMed ID: 3276362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia.
    Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K
    Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
    Mills KI; Sproul AM; Leibowitz D; Burnett AK
    Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia.
    Fioretos T; Heim S; Garwicz S; Ludvigsson J; Mitelman F
    Leukemia; 1992 Jul; 6(7):723-5. PubMed ID: 1625493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival.
    Shepherd P; Suffolk R; Halsey J; Allan N
    Br J Haematol; 1995 Mar; 89(3):546-54. PubMed ID: 7734353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCR rearrangement-negative chronic myelogenous leukemia revisited.
    Kurzrock R; Bueso-Ramos CE; Kantarjian H; Freireich E; Tucker SL; Siciliano M; Pilat S; Talpaz M
    J Clin Oncol; 2001 Jun; 19(11):2915-26. PubMed ID: 11387365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 36. Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia.
    LeBrun DP; Pinkerton PH; Sheridan BL; Chen-Lai J; Dubé ID; Poldre PA
    Cancer Genet Cytogenet; 1991 Jul; 54(1):21-5. PubMed ID: 2065312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratory.
    Haber LM; Childs CC; Hirsch-Ginsberg C; Nellis K; Kantarjian HM; Cork A; Trujillo JM; Stass SA
    Am J Clin Pathol; 1990 Dec; 94(6):762-7. PubMed ID: 2244594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation.
    Chen SJ; Chen Z; Font MP; d'Auriol L; Larsen CJ; Berger R
    Nucleic Acids Res; 1989 Oct; 17(19):7631-42. PubMed ID: 2678002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic myeloid leukemia with minor-bcr breakpoint developed hybrid type of blast crisis.
    Ohno T; Hada S; Sugiyama T; Mizumoto T; Furukawa H; Nagai K
    Am J Hematol; 1998 Apr; 57(4):320-5. PubMed ID: 9544977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.